What type of fluid is xanthochromia (yellow discoloration) used to describe, specifically in relation to cerebrospinal fluid (CSF)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Xanthochromia in Cerebrospinal Fluid Analysis

Xanthochromia refers specifically to the yellow discoloration of cerebrospinal fluid (CSF) after centrifugation, not at initial inspection or in all yellow fluids. 1

Understanding Xanthochromia

Xanthochromia is the yellow discoloration of CSF that occurs due to the breakdown of hemoglobin into bilirubin following a subarachnoid hemorrhage (SAH). This finding is critical in diagnostic medicine for several reasons:

  • It is detected in the supernatant after CSF centrifugation, not in the initial visual inspection of unprocessed CSF 2, 1
  • It develops several hours after bleeding into the subarachnoid space
  • It serves as a key diagnostic marker when CT imaging is negative but SAH is still suspected

Clinical Significance

Xanthochromia analysis is primarily used in the diagnosis of SAH when initial neuroimaging is negative or equivocal:

  • CT sensitivity for SAH decreases over time: 98-100% within 12 hours, 93% at 24 hours, and only 57-85% by day 6 1
  • When performed correctly, CSF xanthochromia testing has excellent diagnostic properties:
    • Sensitivity: 100%
    • Specificity: 98.1%
    • Negative predictive value: 100%
    • Positive predictive value: 65.9% 3

Proper Technique for Xanthochromia Detection

For accurate detection of xanthochromia:

  1. CSF must be collected via lumbar puncture at least 12 hours after symptom onset (ideally after 24 hours) 1, 3
  2. The sample must be centrifuged to separate cellular components from the supernatant
  3. The supernatant is then examined for yellow discoloration
  4. Spectrophotometric analysis is the preferred method for detection, following guidelines such as the UK-NEQAS method 3

Pitfalls and Limitations

Several important caveats must be considered when interpreting xanthochromia:

  • False positives can occur in approximately 13% of LPs 1
  • Traumatic LPs with high RBC counts (>30,000 RBC/μL) can demonstrate xanthochromia immediately after collection 4
  • Samples with 20,000 RBC/μL can show xanthochromia within one hour, and those with 10,000 RBC/μL within two hours 4
  • Other causes of xanthochromia include:
    • Elevated CSF protein (>139 mg/dL)
    • Viral infections like Varicella zoster
    • Mechanical obstruction of CSF flow 5
    • Superficial siderosis in patients with spontaneous intracranial hypotension 2

Diagnostic Algorithm

When SAH is suspected but CT is negative:

  1. Perform lumbar puncture >12 hours after symptom onset (preferably >24 hours)
  2. Centrifuge the CSF sample immediately
  3. Examine the supernatant for xanthochromia (yellow discoloration)
  4. Confirm with spectrophotometric analysis
  5. Interpret results in context of clinical presentation and RBC count:
    • Xanthochromia with <5,000 RBC/μL strongly suggests SAH
    • Xanthochromia with >10,000 RBC/μL may be due to traumatic tap 4

In conclusion, xanthochromia is a valuable diagnostic finding when properly assessed in centrifuged CSF samples, not in the initial visual inspection or in all yellow body fluids.

References

Guideline

Diagnosis and Management of Subarachnoid Hemorrhage

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Xanthochromia is not pathognomonic for subarachnoid hemorrhage.

Academic emergency medicine : official journal of the Society for Academic Emergency Medicine, 2004

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.